DAVIDE CAMPARI-MILANO NV (CPR.MI) Stock Fundamental Analysis
BIT:CPR - Euronext Milan - NL0015435975 - Common Stock - Currency: EUR
We assign a fundamental rating of 3 out of 10 to CPR. CPR was compared to 23 industry peers in the Beverages industry. CPR has an average financial health and profitability rating. CPR is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
CPR had positive earnings in the past year.
In the past year CPR had a positive cash flow from operations.
In the past 5 years CPR has always been profitable.
Each year in the past 5 years CPR had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.38%, CPR is not doing good in the industry: 65.22% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 5.23%, CPR is doing worse than 69.57% of the companies in the same industry.
CPR has a Return On Invested Capital of 6.63%. This is comparable to the rest of the industry: CPR outperforms 52.17% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CPR is in line with the industry average of 7.90%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROIC | 6.63% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
1.3 Margins
Looking at the Profit Margin, with a value of 6.57%, CPR is doing worse than 60.87% of the companies in the same industry.
In the last couple of years the Profit Margin of CPR has declined.
CPR has a Operating Margin of 21.32%. This is in the better half of the industry: CPR outperforms 60.87% of its industry peers.
CPR's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 57.55%, CPR is in the better half of the industry, outperforming 69.57% of the companies in the same industry.
In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% |
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
2. Health
2.1 Basic Checks
CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for CPR has been increased compared to 1 year ago.
Compared to 5 years ago, CPR has more shares outstanding
Compared to 1 year ago, CPR has about the same debt to assets ratio.
2.2 Solvency
CPR has an Altman-Z score of 2.47. This is not the best score and indicates that CPR is in the grey zone with still only limited risk for bankruptcy at the moment.
CPR has a better Altman-Z score (2.47) than 65.22% of its industry peers.
CPR has a debt to FCF ratio of 13.61. This is a negative value and a sign of low solvency as CPR would need 13.61 years to pay back of all of its debts.
CPR has a Debt to FCF ratio of 13.61. This is in the lower half of the industry: CPR underperforms 65.22% of its industry peers.
CPR has a Debt/Equity ratio of 0.66. This is a neutral value indicating CPR is somewhat dependend on debt financing.
CPR has a better Debt to Equity ratio (0.66) than 69.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Altman-Z | 2.47 |
ROIC/WACC0.97
WACC6.85%
2.3 Liquidity
A Current Ratio of 2.37 indicates that CPR has no problem at all paying its short term obligations.
The Current ratio of CPR (2.37) is better than 82.61% of its industry peers.
A Quick Ratio of 0.99 indicates that CPR may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.99, CPR belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 |
3. Growth
3.1 Past
The earnings per share for CPR have decreased strongly by -40.50% in the last year.
CPR shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -8.12% yearly.
The Revenue has been growing slightly by 5.18% in the past year.
The Revenue has been growing by 10.75% on average over the past years. This is quite good.
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
3.2 Future
The Earnings Per Share is expected to grow by 9.99% on average over the next years. This is quite good.
Based on estimates for the next years, CPR will show a small growth in Revenue. The Revenue will grow by 5.57% on average per year.
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y9.99%
Revenue Next Year5.14%
Revenue Next 2Y5.03%
Revenue Next 3Y5.27%
Revenue Next 5Y5.57%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 36.29, CPR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 78.26% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.51, CPR is valued a bit more expensive.
With a Price/Forward Earnings ratio of 18.27, CPR is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 65.22% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of CPR to the average of the S&P500 Index (35.58), we can say CPR is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.29 | ||
| Fwd PE | 18.27 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, CPR is valued a bit more expensive than the industry average as 69.57% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, CPR is valued a bit more expensive than the industry average as 65.22% of the companies are valued more cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.11 | ||
| EV/EBITDA | 13.24 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CPR does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)27.71
PEG (5Y)N/A
EPS Next 2Y6.65%
EPS Next 3Y8.05%
5. Dividend
5.1 Amount
CPR has a Yearly Dividend Yield of 1.03%.
Compared to an average industry Dividend Yield of 2.94, CPR's dividend is way lower than its industry peers. On top of this 91.30% of the companies listed in the same industry pay a better dividend than CPR!
With a Dividend Yield of 1.03, CPR pays less dividend than the S&P500 average, which is at 2.35.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
5.2 History
The dividend of CPR decreases each year by -2.80%.
Dividend Growth(5Y)-2.8%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
38.74% of the earnings are spent on dividend by CPR. This is a low number and sustainable payout ratio.
DP38.74%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
BIT:CPR (7/15/2025, 5:35:30 PM)
6.17
+0.06 (+0.92%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)
Earnings (Next)
Inst Owners21.06%
Inst Owner ChangeN/A
Ins Owners52%
Ins Owner ChangeN/A
Market Cap7.60B
Analysts70.77
Price Target7.04 (14.1%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
Yearly Dividend0.04
Dividend Growth(5Y)-2.8%
DP38.74%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.93%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.93%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.29 | ||
| Fwd PE | 18.27 | ||
| P/S | 2.47 | ||
| P/FCF | 36.11 | ||
| P/OCF | 11.33 | ||
| P/B | 1.97 | ||
| P/tB | 166.6 | ||
| EV/EBITDA | 13.24 |
EPS(TTM)0.17
EY2.76%
EPS(NY)0.34
Fwd EY5.47%
FCF(TTM)0.17
FCFY2.77%
OCF(TTM)0.54
OCFY8.83%
SpS2.49
BVpS3.13
TBVpS0.04
PEG (NY)27.71
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.38% | ||
| ROE | 5.23% | ||
| ROCE | 9.04% | ||
| ROIC | 6.63% | ||
| ROICexc | 6.65% | ||
| ROICexgc | 14.09% | ||
| OM | 21.32% | ||
| PM (TTM) | 6.57% | ||
| GM | 57.55% | ||
| FCFM | 6.85% |
ROA(3y)4.29%
ROA(5y)4.52%
ROE(3y)9.66%
ROE(5y)10.08%
ROIC(3y)7.66%
ROIC(5y)7.27%
ROICexc(3y)8.52%
ROICexc(5y)8.34%
ROICexgc(3y)23.37%
ROICexgc(5y)25.9%
ROCE(3y)10.45%
ROCE(5y)9.91%
ROICexcg growth 3Y-20.45%
ROICexcg growth 5Y-21.73%
ROICexc growth 3Y-7.67%
ROICexc growth 5Y-5.91%
OM growth 3Y3.05%
OM growth 5Y-0.43%
PM growth 3Y-20.58%
PM growth 5Y-17.07%
GM growth 3Y-1.21%
GM growth 5Y-1.11%
F-Score4
Asset Turnover0.36
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.66 | ||
| Debt/FCF | 13.61 | ||
| Debt/EBITDA | 3.27 | ||
| Cap/Depr | 360.3% | ||
| Cap/Sales | 14.99% | ||
| Interest Coverage | 6.99 | ||
| Cash Conversion | 85.71% | ||
| Profit Quality | 104.37% | ||
| Current Ratio | 2.37 | ||
| Quick Ratio | 0.99 | ||
| Altman-Z | 2.47 |
F-Score4
WACC6.85%
ROIC/WACC0.97
Cap/Depr(3y)346.34%
Cap/Depr(5y)266.11%
Cap/Sales(3y)12.99%
Cap/Sales(5y)10.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.5%
EPS 3Y-11.44%
EPS 5Y-8.12%
EPS Q2Q%N/A
EPS Next Y1.31%
EPS Next 2Y6.65%
EPS Next 3Y8.05%
EPS Next 5Y9.99%
Revenue 1Y (TTM)5.18%
Revenue growth 3Y12.21%
Revenue growth 5Y10.75%
Sales Q2Q%N/A
Revenue Next Year5.14%
Revenue Next 2Y5.03%
Revenue Next 3Y5.27%
Revenue Next 5Y5.57%
EBIT growth 1Y6.42%
EBIT growth 3Y15.63%
EBIT growth 5Y10.27%
EBIT Next Year23.05%
EBIT Next 3Y13.08%
EBIT Next 5Y11.08%
FCF growth 1Y232.49%
FCF growth 3Y-14.61%
FCF growth 5Y-4.94%
OCF growth 1Y328.44%
OCF growth 3Y11.5%
OCF growth 5Y13.06%